These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 12150876

  • 1. Substituted hexahydrobenzodipyrans as 5-HT2A/2C receptor probes.
    Whiteside MS, Kurrasch-Orbaugh D, Marona-Lewicka D, Nichols DE, Monte A.
    Bioorg Med Chem; 2002 Oct; 10(10):3301-6. PubMed ID: 12150876
    [Abstract] [Full Text] [Related]

  • 2. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, Nichols DE.
    J Med Chem; 1997 Sep 12; 40(19):2997-3008. PubMed ID: 9301661
    [Abstract] [Full Text] [Related]

  • 3. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.
    Blair JB, Marona-Lewicka D, Kanthasamy A, Lucaites VL, Nelson DL, Nichols DE.
    J Med Chem; 1999 Mar 25; 42(6):1106-11. PubMed ID: 10090793
    [Abstract] [Full Text] [Related]

  • 4. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
    Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE.
    J Med Chem; 2000 Nov 30; 43(24):4701-10. PubMed ID: 11101361
    [Abstract] [Full Text] [Related]

  • 5. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
    Smith RL, Canton H, Barrett RJ, Sanders-Bush E.
    Pharmacol Biochem Behav; 1998 Nov 30; 61(3):323-30. PubMed ID: 9768567
    [Abstract] [Full Text] [Related]

  • 6. 1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.
    Nichols DE, Frescas S, Marona-Lewicka D, Huang X, Roth BL, Gudelsky GA, Nash JF.
    J Med Chem; 1994 Dec 09; 37(25):4346-51. PubMed ID: 7996545
    [Abstract] [Full Text] [Related]

  • 7. 5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat.
    Marona-Lewicka D, Nichols DE.
    Neuropharmacology; 1997 Oct 09; 36(10):1471-5. PubMed ID: 9423936
    [Abstract] [Full Text] [Related]

  • 8. Contribution of a helix 5 locus to selectivity of hallucinogenic and nonhallucinogenic ligands for the human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors: direct and indirect effects on ligand affinity mediated by the same locus.
    Almaula N, Ebersole BJ, Ballesteros JA, Weinstein H, Sealfon SC.
    Mol Pharmacol; 1996 Jul 09; 50(1):34-42. PubMed ID: 8700116
    [Abstract] [Full Text] [Related]

  • 9. Activities of novel aryloxyalkylimidazolines on rat 5-HT2A and 5-HT2C receptors.
    Siegel BW, Freedman J, Vaal MJ, Baron BM.
    Eur J Pharmacol; 1996 Feb 05; 296(3):307-18. PubMed ID: 8904083
    [Abstract] [Full Text] [Related]

  • 10. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA, Harvey JA, Aloyo VJ.
    Brain Res; 2013 Jan 23; 1491():98-108. PubMed ID: 23123701
    [Abstract] [Full Text] [Related]

  • 11. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE, Harrington AW, Eckler JR, Arshad S, Rabin RA, Winter JC, Coop A, Rice KC, Woods JH.
    Psychopharmacology (Berl); 2005 Sep 23; 181(3):496-503. PubMed ID: 15983786
    [Abstract] [Full Text] [Related]

  • 12. Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
    Egan CT, Herrick-Davis K, Miller K, Glennon RA, Teitler M.
    Psychopharmacology (Berl); 1998 Apr 23; 136(4):409-14. PubMed ID: 9600588
    [Abstract] [Full Text] [Related]

  • 13. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ, Smith RL, Barrett RJ, Sanders-Bush E.
    Neuropsychopharmacology; 2005 Sep 23; 30(9):1693-702. PubMed ID: 15756304
    [Abstract] [Full Text] [Related]

  • 14. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs.
    Newton RA, Phipps SL, Flanigan TP, Newberry NR, Carey JE, Kumar C, McDonald B, Chen C, Elliott JM.
    J Neurochem; 1996 Dec 23; 67(6):2521-31. PubMed ID: 8931486
    [Abstract] [Full Text] [Related]

  • 15. Agonist-directed signaling of serotonin 5-HT2C receptors: differences between serotonin and lysergic acid diethylamide (LSD).
    Backstrom JR, Chang MS, Chu H, Niswender CM, Sanders-Bush E.
    Neuropsychopharmacology; 1999 Aug 23; 21(2 Suppl):77S-81S. PubMed ID: 10432492
    [Abstract] [Full Text] [Related]

  • 16. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ, Aghajanian GK.
    J Pharmacol Exp Ther; 1996 Sep 23; 278(3):1373-82. PubMed ID: 8819525
    [Abstract] [Full Text] [Related]

  • 17. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J, Hanniford D, Doucette C, Graham E, Poole MF, Ting A, Sherf B, Harrington J, Brunden K, Stricker-Krongrad A.
    Assay Drug Dev Technol; 2005 Dec 23; 3(6):649-59. PubMed ID: 16438660
    [Abstract] [Full Text] [Related]

  • 18. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors.
    Krebs-Thomson K, Paulus MP, Geyer MA.
    Neuropsychopharmacology; 1998 May 23; 18(5):339-51. PubMed ID: 9536447
    [Abstract] [Full Text] [Related]

  • 19. Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).
    Nichols DE, Frescas S, Marona-Lewicka D, Kurrasch-Orbaugh DM.
    J Med Chem; 2002 Sep 12; 45(19):4344-9. PubMed ID: 12213075
    [Abstract] [Full Text] [Related]

  • 20. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
    Arvanov VL, Liang X, Russo A, Wang RY.
    Eur J Neurosci; 1999 Sep 12; 11(9):3064-72. PubMed ID: 10510170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.